AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2013
Aug 16, 2013
34519_dirs_2013-08-16_5b810afc-1d86-4275-ae26-917f40e36d93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2013-08-14
Reporting Person: Cunningham David (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 162 | $3.6 | Acquired | 162 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 38 | $3.6 | Acquired | 200 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 100 | $3.6 | Acquired | 300 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 62 | $3.65 | Acquired | 362 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 500 | $3.65 | Acquired | 862 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 100 | $3.65 | Acquired | 962 | Direct |
| 2013-08-14 | Common Stock, par value $0.10 per share | P | 38 | $3.65 | Acquired | 1000 | Direct |
| 2013-08-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.7 | Acquired | 2000 | Direct |
| 2013-08-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.7 | Acquired | 3000 | Direct |
| 2013-08-16 | Common Stock, par value $0.10 per share | P | 36 | $3.7 | Acquired | 3036 | Direct |
| 2013-08-16 | Common Stock, par value $0.10 per share | P | 100 | $3.69 | Acquired | 3136 | Direct |
| 2013-08-16 | Common Stock, par value $0.10 per share | P | 100 | $3.7 | Acquired | 3236 | Direct |
| 2013-08-16 | Common Stock, par value $0.10 per share | P | 764 | $3.7 | Acquired | 4000 | Direct |
Footnotes
F1: These shares are beneficially owned by the Cunningham Family Revocable Trust, of which Mr. Cunningham is a beneficiary.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23